European Journal of Medicinal Chemistry p. 401 - 413 (2017)
Update date:2022-07-30
Topics:
Thum, Simone
Kokornaczyk, Artur K.
Seki, Tomoaki
De Maria, Monica
Ortiz Zacarias, Natalia V.
de Vries, Henk
Weiss, Christina
Koch, Michael
Schepmann, Dirk
Kitamura, Masato
Tschammer, Nuska
Heitman, Laura H.
Junker, Anna
Wünsch, Bernhard
Targeting CCR2 and CCR5 receptors is considered as promising concept for the development of novel antiinflammatory drugs. Herein, we present the development of the first probe-dependent positive allosteric modulator (PAM) of CCR5 receptors with a 2-benzazepine scaffold. Compound 14 (2-isobutyl-N-({[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl}phenyl)-1-oxo-2,3-dihydro-1H-2-benzazepine-4-carboxamide) activates the CCR5 receptor in a CCL4-dependent manner, but does not compete with [3H]TAK-779 binding at the CCR5. Furthermore, introduction of a p-tolyl moiety at 7-position of the 2-benzazepine scaffold turns the CCR5 PAM 14 into the selective CCR2 receptor antagonist 26b. The structure affinity and activity relationships presented here offer new insights into ligand recognition by CCR2 and CCR5 receptors.
View MoreShijiazhuang Haitian Amino Acid Co., Ltd.
Contact:+86-311-88908111
Address:Shijiazhuang Hebei province,China
Contact:0792-8228321
Address:10TH Floor No.121 binjiang Road Xunyang District
SICHUAN ZHONGBANG NEW MATERIAL CO., LTD
website:http://www.zhongbangst.com
Contact:86-830-2585019
Address:sichuan,china
YingYing Pharmaceutical Co.,Ltd
Contact:86-18854126208
Address:55#, yingxiongshan road
website:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
Doi:10.1016/S0277-5387(97)00391-4
(1998)Doi:10.1039/c0ob00154f
(2010)Doi:10.1016/j.carres.2010.08.002
(2010)Doi:10.1055/s-0030-1258137
(2010)Doi:10.1016/S0040-4020(01)80540-8
(1993)Doi:10.1021/ja1025497
(2010)